Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age70+
SponsorPenn State University

About this trial

The goal of this step-wedge trial is to test the implementation of daily nurse screening for delirium in routine care and its impact on outcomes and complications in hospitalized older adults admitted to 6 general medicine/surgery units at 3 hospitals in Pennsylvania and Massachusetts.

The main question\[s\] it aims to answer are:

* 1\. To test the fidelity, accuracy, and durability of implementing daily nurse screening for delirium using the UB-CAM in routine care. * 2\. To evaluate the impact of UB-CAM delirium screening on patient and care partner centered outcomes assessed at one month follow-up interviews 3. To evaluate the impact of UB-CAM screening on rates of delirium complications (falls, pressure injury, aspiration) and adverse delirium management (psychoactive medication use, restraint use).

Participants (patients) will be assessed for delirium on study days 1, 2 and 3 (or until hospital discharge) and will be asked basic demographics. These patients will be contacted by phone 1 month after enrollment to collect information about inpatient facility use and to administer the Delirium Burden Patient Scale.

Participants (care partners) will be interviewed at the patient's discharge to complete the Alzheimer's Disease-8 scale. These care partners will be contacted by phone 1 month after enrollment to complete the Delirium Burden Caregiver Scale and to complete a Qualitative Interview which includes questions about communication and collaboration.

Eligibility criteria

Qualifiers

General medicine (hospitalist) service

Age 70 or older

Expected hospital length of stay of 3 or more days

Disqualifiers

Inability to communicate adequately in English

Admitted for terminal care

Trial design

Treatments tested in this trial

  • READI-SET GO UB-CAM delirium screening into EHR

Treatment groups

1,050 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Penn State University

Lead sponsor

Mount Nittany Medical Center

Collaborator

Beth Israel Deaconess Medical Center

Collaborator

Penn State Health Milton S Hershey Medical Center

Collaborator